NEWMED ENERGY - LIMITED PARTNERSHIP Financials NewMed Energy - Limited Partnership
Equities
NWMD
IL0004750209
Oil & Gas Exploration and Production
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 956.4 ILa | -0.85% |
|
-0.89% | -8.04% |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Capitalization 1 | 12,208 | 11,323 | - |
| Enterprise Value (EV) 1 | 18,185 | 16,541 | 15,367 |
| P/E ratio | - | - | - |
| Yield | - | - | - |
| Capitalization / Revenue | - | - | - |
| EV / Revenue | - | - | - |
| EV / EBITDA | - | - | - |
| EV / FCF | 11.7 x | 7.89 x | 7.58 x |
| FCF Yield | 8.54% | 12.7% | 13.2% |
| Price to Book | - | - | - |
| Nbr of stocks (in thousands) | 1,173,815 | 1,173,815 | - |
| Reference price 2 | 10.40 | 9.646 | 9.646 |
| Announcement Date | 3/19/24 | - | - |
1ILS in Million2ILS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net sales | - | - | - |
| EBITDA | - | - | - |
| EBIT | - | - | - |
| Operating Margin | - | - | - |
| Earnings before Tax (EBT) | - | - | - |
| Net income | - | - | - |
| Net margin | - | - | - |
| EPS | - | - | - |
| Free Cash Flow 1 | 1,553 | 2,097 | 2,028 |
| FCF margin | - | - | - |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 3/19/24 | - | - |
1ILS in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 |
|---|---|---|---|
| Net Debt 1 | 5,977 | 5,219 | 4,044 |
| Net Cash position 1 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - |
| Free Cash Flow 1 | 1,553 | 2,097 | 2,028 |
| ROE (net income / shareholders' equity) | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - |
| Assets | - | - | - |
| Book Value Per Share | - | - | - |
| Cash Flow per Share | - | - | - |
| Capex | - | - | - |
| Capex / Sales | - | - | - |
| Announcement Date | 3/19/24 | - | - |
1ILS in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
9.646
ILS
Average target price
11.3
ILS
Spread / Average Target
+17.15%
| 1st Jan change | Capi. | |
|---|---|---|
| -8.04% | 3.06B | |
| +27.27% | 509M | |
| -22.61% | 105M | |
| +10.93% | 79.73M |
- Stock Market
- Equities
- NWMD Stock
- Financials NewMed Energy - Limited Partnership